0001493152-21-008150.txt : 20210407
0001493152-21-008150.hdr.sgml : 20210407
20210407094101
ACCESSION NUMBER: 0001493152-21-008150
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210407
FILED AS OF DATE: 20210407
DATE AS OF CHANGE: 20210407
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sharon Simon
CENTRAL INDEX KEY: 0001851272
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19871
FILM NUMBER: 21810944
MAIL ADDRESS:
STREET 1: 8 HAMADA STREET
CITY: ZICHRON YAACOV
STATE: L3
ZIP: 3090708
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Microbot Medical Inc.
CENTRAL INDEX KEY: 0000883975
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 943078125
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 25 RECREATION PARK DR SUITE 108
CITY: HINGHAM
STATE: MA
ZIP: 02043
BUSINESS PHONE: 908-938-5561
MAIL ADDRESS:
STREET 1: 25 RECREATION PARK DR SUITE 108
CITY: HINGHAM
STATE: MA
ZIP: 02043
FORMER COMPANY:
FORMER CONFORMED NAME: STEMCELLS INC
DATE OF NAME CHANGE: 20000524
FORMER COMPANY:
FORMER CONFORMED NAME: CYTOTHERAPEUTICS INC/DE
DATE OF NAME CHANGE: 19930328
3
1
ownership.xml
X0206
3
2021-04-07
0
0000883975
Microbot Medical Inc.
MBOT
0001851272
Sharon Simon
C/O MICROBOT MEDICAL INC.
25 RECREATION PARK DRIVE, UNIT 108
HINGHAM,
MA
02043
0
1
0
0
General Manager & CTO
Stock Option (Right to Buy)
9.00
2028-08-13
Common Stock, par value $0.01 per share
10000
D
Stock Option (Right to Buy)
5.95
2029-08-12
Common Stock, par value $0.01 per share
14170
D
The option vests as follows and in accordance with the terms of the Issuer's 2017 Equity Incentive Plan: (a) on February 13, 2019, the option vested and became exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock.
The option vests as follows and in accordance with the terms of the Issuer's 2017 Equity Incentive Plan: (a) on February 12, 2020, the option vested and became exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock.
/s/ Simon Sharon
2021-04-07